Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $77.3400 (-1.28%) ($77.0900 - $77.3400) on Fri. Nov. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.12% (three month average) | RSI | 42 | Latest Price | $77.3400(-1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND advances 4.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWN(45%) IWM(44%) IWC(42%) IWO(42%) SDY(39%) | Factors Impacting LGND price | LGND will decline at least -2.06% in a week (0% probabilities). VXX(-20%) SHY(-7%) UNG(-5%) XBI(-4%) SLV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.06% (StdDev 4.12%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $78.13 | 5 Day Moving Average | $78.93(-2.01%) | 10 Day Moving Average | $76.84(0.65%) | 20 Day Moving Average | $78.13(-1.01%) | To recent high | -25.8% | To recent low | 25.1% | Market Cap | $1.243b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |